Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, van den Hoogen FH, Donders AR, Evers A. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. Randomized Controlled Trial. N Engl J Med. 2016;374(13):1209-20. doi: 10.1056/NEJMoa1505425.
Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: A rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015:57:82-115. doi: 10.1016/j.jaut.2014.09.004.
Dessau RB, Bangsborg J, Hansen K, Lebech AM, Sellebjerg FT, Skarphédinson S, Østergaard C. Lyme Borreliose: Klinik, diagnostik og behandling i Danmark. (2. utgave). 2014. http://dskm.dk/onewebmedia/Borrelia%20klaringsrapport%202.udgave%202014.pdf
Eikeland R. Nevroborreliose. Norsk Elektronisk Legehåndbok - Nevrologi. Oppdatert 31.10.2022
Eliassen KE, Berild D, Reiso H, Grude N, Christophersen KS, Finckenhagen C, Lindbæk M. Incidence and antibiotic treatment of erythema migrans in Norway 2005-2009. Ticks Tick Borne Dis. 2017;8(1):1-8. doi: 10.1016/j.ttbdis.2016.06.006.
Hagberg, L. Borrelia. www.internetmedicin.se. 2023.
Haugeberg G, Hansen IJ, Skarpaas T, Noraas S, Kjelland V. Lyme arthritis in Southern Norway--an endemic area for Lyme borreliosis. BMC Infect Dis. 2014;14:185.
Helsedirektoratet. Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Oppdatert 01.03.2024
Helsedirektoratet. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Oppdatert 2022.
Knudtzen FC, Andersen NS, Jensen TG, Skarphédinsson W, Kullberg BJ. Characteristics and Clinical Outcome of Lyme Neuroborreliosis in a High Endemic Area, 1995-2014: A Retrospective Cohort Study in Denmark. Clin Infect Dis. 2017;65(9):1489-1495. doi: 10.1093/cid/cix568.
Kristiansen BE, Grude N, Tveten Y, Emmert A. Laboratoriediagnostikk av Lyme-borreliose. Tidsskr Nor Laegeforen. 2009;129(20):2132-4. doi: 10.4045/tidsskr.09.0849.
Ljøstad, U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg Å, Mygland Å. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690-695
Raffetin A, Henningsson AJ, Ornstein K, Arias P, Fingerle V, Patrat-Delon S, Bremell D, Lindgren PE, Rupprecht TA, Jaulhac B, Hunfeld KP, Cazorla C, Markowicz M, Lienhard R, van Dam AP, Baux E, Mavin S, Hovius JW, Baarsma ME, Berg KK, Eikeland R, Dessau RB; ESGBOR the ESCMID study group for Tick-Borne Diseases. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis. Infection. 2025 Jun;53(3):809-830. doi: 10.1007/s15010-025-02501-3.
Stanek G, Fingerle V, Hunfeld K-P, Jaulhac B, Kaiser B, Krause A, Kristoferitsch W, O’Connell S, Ornstein K, Strle F, Gray J. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011; 17(1):69-79. doi: 10.1111/j.1469-0691.2010.03175.x.
Wormser GP, Dattwyler RJ, Shapiro ED et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-134. doi: 10.1086/508667
Øymar K, Tveitnes D. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand J Infect Dis. 2009;41(2):88-94. doi: 10.1080/00365540802593453.